BSEBoard Meeting31 Oct 2026 · 31 Oct 2026, 06:36 pm
Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Unaudited Financial Results for quarter and half year ended September 30, 2026
Titan Biotech Ltd · 524717
✦ AI SummaryResults
Titan Biotech Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 05/11/2026 to consider and approve Unaudited Financial Results for quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Titan Biotech Ltd - 524717 - Board Meeting Intimation for Inter Alia Consideration And Approval Of Unaudited Financial Results For Quarter And Half Year Ended September 30, 2026